154 related articles for article (PubMed ID: 20800500)
1. Design and synthesis of de novo cytotoxic alkaloids by mimicking the bioactive conformation of paclitaxel.
Sun L; Veith JM; Pera P; Bernacki RJ; Ojima I
Bioorg Med Chem; 2010 Oct; 18(19):7101-12. PubMed ID: 20800500
[TBL] [Abstract][Full Text] [Related]
2. Rotational-echo double-resonance NMR distance measurements for the tubulin-bound Paclitaxel conformation.
Paik Y; Yang C; Metaferia B; Tang S; Bane S; Ravindra R; Shanker N; Alcaraz AA; Johnson SA; Schaefer J; O'Connor RD; Cegelski L; Snyder JP; Kingston DG
J Am Chem Soc; 2007 Jan; 129(2):361-70. PubMed ID: 17212416
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of simplified taxol analogs based on the T-Taxol bioactive conformation.
Zhao J; Bane S; Snyder JP; Hu H; Mukherjee K; Slebodnick C; Kingston DG
Bioorg Med Chem; 2011 Dec; 19(24):7664-78. PubMed ID: 22071526
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the tubulin-bound paclitaxel conformation: synthesis, biology, and SAR studies of C-4 to C-3' bridged paclitaxel analogues.
Ganesh T; Yang C; Norris A; Glass T; Bane S; Ravindra R; Banerjee A; Metaferia B; Thomas SL; Giannakakou P; Alcaraz AA; Lakdawala AS; Snyder JP; Kingston DG
J Med Chem; 2007 Feb; 50(4):713-25. PubMed ID: 17263521
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and bioactivity of simplified paclitaxel analogs based on the T-Taxol bioactive conformation.
Ganesh T; Norris A; Sharma S; Bane S; Alcaraz AA; Snyder JP; Kingston DG
Bioorg Med Chem; 2006 May; 14(10):3447-54. PubMed ID: 16434198
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of (+)-discodermolide-paclitaxel hybrids leading to enhanced biological activity.
Smith AB; Sugasawa K; Atasoylu O; Yang CP; Horwitz SB
J Med Chem; 2011 Sep; 54(18):6319-27. PubMed ID: 21870795
[TBL] [Abstract][Full Text] [Related]
7. Bridging converts a noncytotoxic nor-paclitaxel derivative to a cytotoxic analogue by constraining it to the T-Taxol conformation.
Tang S; Yang C; Brodie P; Bane S; Ravindra R; Sharma S; Jiang Y; Snyder JP; Kingston DG
Org Lett; 2006 Aug; 8(18):3983-6. PubMed ID: 16928054
[TBL] [Abstract][Full Text] [Related]
8. Use of the tubulin bound paclitaxel conformation for structure-based rational drug design.
Geney R; Sun L; Pera P; Bernacki RJ; Xia S; Horwitz SB; Simmerling CL; Ojima I
Chem Biol; 2005 Mar; 12(3):339-48. PubMed ID: 15797218
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro Biological Evaluation of Ferrocenyl Side-Chain-Functionalized Paclitaxel Derivatives.
Plażuk D; Wieczorek A; Ciszewski WM; Kowalczyk K; Błauż A; Pawlędzio S; Makal A; Eurtivong C; Arabshahi HJ; Reynisson J; Hartinger CG; Rychlik B
ChemMedChem; 2017 Nov; 12(22):1882-1892. PubMed ID: 28941201
[TBL] [Abstract][Full Text] [Related]
10. Biological evaluation of new antitumor taxoids: alteration of substitution at the C-7 and C-10 of docetaxel.
Li C; Qiu Y; Li X; Liu N; Yao Z
Bioorg Med Chem Lett; 2014 Feb; 24(3):855-9. PubMed ID: 24405702
[TBL] [Abstract][Full Text] [Related]
11. The T-Taxol conformation.
Alcaraz AA; Mehta AK; Johnson SA; Snyder JP
J Med Chem; 2006 Apr; 49(8):2478-88. PubMed ID: 16610791
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the study of the bioactive conformation of taxol.
Sun L; Simmerling C; Ojima I
ChemMedChem; 2009 May; 4(5):719-31. PubMed ID: 19360801
[TBL] [Abstract][Full Text] [Related]
13. Spiro-bicyclo[2.2.2]octane derivatives as paclitaxel mimetics. Synthesis and toxicity evaluation in breast cancer cell lines.
Manner S; Oltner VT; Oredsson S; Ellervik U; Frejd T
Org Biomol Chem; 2013 Nov; 11(41):7134-44. PubMed ID: 24057031
[TBL] [Abstract][Full Text] [Related]
14. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.
Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC
Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162
[TBL] [Abstract][Full Text] [Related]
15. Preclinical pharmacologic evaluation of MST-997, an orally active taxane with superior in vitro and in vivo efficacy in paclitaxel- and docetaxel-resistant tumor models.
Sampath D; Greenberger LM; Beyer C; Hari M; Liu H; Baxter M; Yang S; Rios C; Discafani C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3459-69. PubMed ID: 16740771
[TBL] [Abstract][Full Text] [Related]
16. Diastereomers of dibromo-7-epi-10-deacetylcephalomannine: crowded and cytotoxic taxanes exhibit halogen bonds.
Jiang Y; Alcaraz AA; Chen JM; Kobayashi H; Lu YJ; Snyder JP
J Med Chem; 2006 Mar; 49(6):1891-9. PubMed ID: 16539375
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and cytotoxic activity of novel spin-labeled rotenone derivatives.
Liu YQ; Ohkoshi E; Li LH; Yang L; Lee KH
Bioorg Med Chem Lett; 2012 Jan; 22(2):920-3. PubMed ID: 22204911
[TBL] [Abstract][Full Text] [Related]
18. The tubulin-bound conformation of paclitaxel: T-taxol vs "PTX-NY".
Yang Y; Alcaraz AA; Snyder JP
J Nat Prod; 2009 Mar; 72(3):422-9. PubMed ID: 19267457
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and SAR requirements of adamantane-colchicine conjugates with both microtubule depolymerizing and tubulin clustering activities.
Zefirova ON; Nurieva EV; Shishov DV; Baskin II; Fuchs F; Lemcke H; Schröder F; Weiss DG; Zefirov NS; Kuznetsov SA
Bioorg Med Chem; 2011 Sep; 19(18):5529-38. PubMed ID: 21873068
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel macrocyclic docetaxel analogues. Influence of their macrocyclic ring size on tubulin activity.
Querolle O; Dubois J; Thoret S; Roussi F; Montiel-Smith S; Guéritte F; Guénard D
J Med Chem; 2003 Aug; 46(17):3623-30. PubMed ID: 12904066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
